{"id":"https://openalex.org/W2757581310","doi":"https://doi.org/10.3390/ijms18102021","title":"Angiogenesis Inhibitors in NSCLC","display_name":"Angiogenesis Inhibitors in NSCLC","alternate_titles":[],"publication_year":2017,"publication_date":"2017-09-21","ids":{"openalex":"https://openalex.org/W2757581310","doi":"https://doi.org/10.3390/ijms18102021","mag":"2757581310","pmid":"https://pubmed.ncbi.nlm.nih.gov/28934120","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5666703"},"language":"en","primary_location":{"id":"doi:10.3390/ijms18102021","doi":"https://doi.org/10.3390/ijms18102021","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms18102021","pdf_url":"https://www.mdpi.com/1422-0067/18/10/2021/pdf?version=1505996853","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2757581310"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1422-0067/18/10/2021/pdf?version=1505996853","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087886547","display_name":"Anna Manzo","orcid":"https://orcid.org/0000-0002-9608-8865","observed_orcids":["https://orcid.org/0000-0002-9608-8865"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Manzo","raw_affiliation_strings":["Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031019737","display_name":"Agnese Montanino","orcid":"https://orcid.org/0000-0003-4271-8275","observed_orcids":["https://orcid.org/0000-0003-4271-8275"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Agnese Montanino","raw_affiliation_strings":["Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015965477","display_name":"Guido Carillio","orcid":"https://orcid.org/0000-0002-7652-9432","observed_orcids":["https://orcid.org/0000-0002-7652-9432"]},"institutions":[{"id":"https://openalex.org/I4210148440","display_name":"Azienda Ospedaliera Pugliese Ciaccio","ror":"https://ror.org/053y0qd29","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210148440"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Guido Carillio","raw_affiliation_strings":["Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, 88100 Catanzaro, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, 88100 Catanzaro, Italy","institution_ids":["https://openalex.org/I4210148440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091532757","display_name":"Raffaele Costanzo","orcid":"https://orcid.org/0009-0001-1572-404X","observed_orcids":["https://orcid.org/0009-0001-1572-404X","https://orcid.org/0009-0005-4698-5102","https://orcid.org/0000-0001-9108-5609"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Raffaele Costanzo","raw_affiliation_strings":["Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020456545","display_name":"Claudia Sandomenico","orcid":"https://orcid.org/0000-0003-3709-0807","observed_orcids":["https://orcid.org/0000-0003-3709-0807"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Sandomenico","raw_affiliation_strings":["Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003014678","display_name":"Nicola Normanno","orcid":"https://orcid.org/0000-0002-7158-2605","observed_orcids":["https://orcid.org/0000-0002-7158-2605"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Normanno","raw_affiliation_strings":["Cellular Biology and Biotherapy, Research Department, Istituto Nazionale Tumori \u201cFondazione G.Pascale\u201d\u2014IRCCS, Napoli 80131, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Biology and Biotherapy, Research Department, Istituto Nazionale Tumori \u201cFondazione G.Pascale\u201d\u2014IRCCS, Napoli 80131, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062149201","display_name":"Maria Carmela Piccirillo","orcid":"https://orcid.org/0000-0001-9519-4757","observed_orcids":["https://orcid.org/0000-0001-9519-4757"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Piccirillo","raw_affiliation_strings":["Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079782055","display_name":"Gennaro Daniele","orcid":"https://orcid.org/0000-0001-5360-1895","observed_orcids":["https://orcid.org/0000-0001-5360-1895"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gennaro Daniele","raw_affiliation_strings":["Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102804100","display_name":"Francesco Perrone","orcid":"https://orcid.org/0000-0002-9738-0526","observed_orcids":["https://orcid.org/0000-0002-9738-0526"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Perrone","raw_affiliation_strings":["Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Unit, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002665417","display_name":"Gaetano Rocco","orcid":"https://orcid.org/0000-0003-4150-8604","observed_orcids":["https://orcid.org/0000-0003-4150-8604"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gaetano Rocco","raw_affiliation_strings":["Thoracic Surgery, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Surgery, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051933262","display_name":"Alessandro Morabito","orcid":"https://orcid.org/0000-0002-1319-9608","observed_orcids":["https://orcid.org/0000-0002-1319-9608"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandro Morabito","raw_affiliation_strings":["Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, Istituto Nazionale Tumori, \u201cFondazione G.Pascale\u201d\u2014IRCCS, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5051933262"],"corresponding_institution_ids":["https://openalex.org/I4210141868"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":1.3361,"has_fulltext":true,"cited_by_count":109,"citation_normalized_percentile":{"value":0.79595077,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"18","issue":"10","first_page":"2021","last_page":"2021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.319599986076355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":1.0},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9369999766349792},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8100000023841858},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7210000157356262},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6370000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8140000104904175},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8762877583503723},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8108663558959961},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.7992749810218811},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7519428730010986},{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.7364509105682373},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.688849151134491},{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.6786537170410156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6581008434295654},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.5628146529197693},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5088110566139221},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.47378870844841003},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.433284193277359},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.43325868248939514},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.4150315225124359},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4141348600387573},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4098927974700928},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3549720346927643},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.20426642894744873},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.18247848749160767},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.16621717810630798},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000096662","descriptor_name":"Ramucirumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3390/ijms18102021","doi":"https://doi.org/10.3390/ijms18102021","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms18102021","pdf_url":"https://www.mdpi.com/1422-0067/18/10/2021/pdf?version=1505996853","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},{"id":"pmid:28934120","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28934120","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of molecular sciences","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5666703","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5666703/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Mol Sci","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3390/ijms18102021","doi":"https://doi.org/10.3390/ijms18102021","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms18102021","pdf_url":"https://www.mdpi.com/1422-0067/18/10/2021/pdf?version=1505996853","source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2757581310.pdf","grobid_xml":"https://content.openalex.org/works/W2757581310.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W937443458","https://openalex.org/W1490955258","https://openalex.org/W1757407923","https://openalex.org/W1868293759","https://openalex.org/W1965727465","https://openalex.org/W1978111504","https://openalex.org/W1978139448","https://openalex.org/W1983700723","https://openalex.org/W2000227671","https://openalex.org/W2000292756","https://openalex.org/W2002049222","https://openalex.org/W2012368323","https://openalex.org/W2016641845","https://openalex.org/W2019204011","https://openalex.org/W2033119689","https://openalex.org/W2053663663","https://openalex.org/W2063490878","https://openalex.org/W2064926421","https://openalex.org/W2077125884","https://openalex.org/W2089756110","https://openalex.org/W2098683814","https://openalex.org/W2101711321","https://openalex.org/W2102590541","https://openalex.org/W2105464202","https://openalex.org/W2109823414","https://openalex.org/W2110810263","https://openalex.org/W2112524831","https://openalex.org/W2114940128","https://openalex.org/W2115078104","https://openalex.org/W2122798232","https://openalex.org/W2124464299","https://openalex.org/W2125082715","https://openalex.org/W2134693386","https://openalex.org/W2136601558","https://openalex.org/W2140980839","https://openalex.org/W2141236760","https://openalex.org/W2144660856","https://openalex.org/W2145835533","https://openalex.org/W2152376701","https://openalex.org/W2153297361","https://openalex.org/W2155338842","https://openalex.org/W2159370421","https://openalex.org/W2160373161","https://openalex.org/W2163351155","https://openalex.org/W2168752603","https://openalex.org/W2170024262","https://openalex.org/W2170030318","https://openalex.org/W2249498798","https://openalex.org/W2304373741","https://openalex.org/W2340863814","https://openalex.org/W2406472512","https://openalex.org/W2466485850","https://openalex.org/W2489765770","https://openalex.org/W2506327908","https://openalex.org/W2528861955","https://openalex.org/W2599454896","https://openalex.org/W2606131767","https://openalex.org/W2764085044","https://openalex.org/W2890643511","https://openalex.org/W6650204128"],"related_works":["https://openalex.org/W2016548318","https://openalex.org/W2005361820","https://openalex.org/W155982068","https://openalex.org/W1829889233","https://openalex.org/W2797415837","https://openalex.org/W2551341750","https://openalex.org/W2808479470","https://openalex.org/W2022555151","https://openalex.org/W3032512835","https://openalex.org/W2794945244"],"abstract_inverted_index":{"Angiogenesis":[0],"is":[1],"a":[2,8,127,200,204],"complex":[3],"biological":[4],"process":[5],"that":[6,73],"plays":[7],"relevant":[9],"role":[10],"in":[11,43,81,85,89,95,113,131,195],"sustaining":[12],"the":[13,30,36,63,90,135,142,168,176,208,224],"microenvironment,":[14],"growth,":[15],"and":[16,56,71,88,107,115,124,188,216],"metastatic":[17],"potential":[18],"of":[19,38,65,77,145,179,211,226],"several":[20],"tumors,":[21],"including":[22,104],"non-small":[23],"cell":[24],"lung":[25],"cancer":[26],"(NSCLC).":[27],"Bevacizumab":[28],"was":[29,49,60],"first":[31,114],"angiogenesis":[32],"inhibitor":[33],"approved":[34],"for":[35,207],"treatment":[37,210],"patients":[39,52,146,180,196,212],"with":[40,45,53,147,153,181,197,213],"advanced":[41,214],"NSCLC":[42,150,215],"combination":[44],"chemotherapy;":[46],"however,":[47],"it":[48,202],"limited":[50],"to":[51,222],"non-squamous":[54],"histology":[55,149,184],"first-line":[57],"setting.":[58,133],"Approval":[59],"based":[61],"on":[62],"results":[64],"two":[66,79,119],"phase":[67],"III":[68],"trials":[69],"(ECOG4599":[70],"AVAIL)":[72],"demonstrated":[74],"an":[75,93,230],"improvement":[76,94],"about":[78],"months":[80],"progression-free":[82],"survival":[83,97,129],"(PFS)":[84],"both":[86],"trials,":[87],"ECOG4599":[91],"trial,":[92],"overall":[96],"(OS)":[98],"also.":[99],"Afterwards,":[100],"other":[101],"antiangiogenic":[102,121,227],"agents,":[103],"sunitinib,":[105],"sorafenib,":[106],"vandetanib":[108],"have":[109],"been":[110],"unsuccessfully":[111],"tested":[112],"successive":[116],"lines.":[117],"Recently,":[118],"new":[120,205],"agents":[122],"(ramucirumab":[123],"nintedanib)":[125],"produced":[126],"significant":[128],"benefit":[130,225],"second-line":[132,209],"In":[134,167],"REVEL":[136],"study,":[137,171],"ramucirumab":[138],"plus":[139,173],"docetaxel":[140,154,174],"prolonged":[141,175],"median":[143,177],"OS":[144,190],"any":[148,182],"when":[151],"compared":[152],"alone":[155],"(10.4":[156],"versus":[157,192],"9.1":[158],"months,":[159],"hazard":[160],"ratio":[161],"(HR)":[162],"0.857,":[163],"p":[164],"=":[165,186],"0.0235).":[166],"LUME-Lung":[169],"1":[170],"nintedanib":[172],"PFS":[178],"tumor":[183],"(p":[185],"0.0019),":[187],"improved":[189],"(12.6":[191],"10.3":[193],"months)":[194],"adenocarcinoma.":[198],"As":[199],"result,":[201],"became":[203],"option":[206],"adenocarcinoma":[217],"histology.":[218],"Identifying":[219],"predictive":[220],"biomarkers":[221],"optimize":[223],"drugs":[228],"remains":[229],"ongoing":[231],"challenge.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2757581310","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-10-06T00:00:00"}
